Department of Health
and Human Services (HHS)
and Human Services (HHS)
June 21, 2021
RFA-CA-21-033 - The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)
RFA-CA-21-034 - The Early Detection Research Network: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed)
RFA-CA-21-035 - The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
National Cancer Institute (NCI)
The National Cancer Institute (NCI) will hold a public pre-application teleconference on July 12, 2021 and on August 9, 2021, at the times indicated for each of the three related Funding Opportunity Announcements (FOAs):
1) RFA-CA-21-035 - The Early Detection Research Network: Biomarker Characterization Centers (U2C): at 11:00 am - 12:30 pm EDT;
2) RFA-CA-21-033 - The Early Detection Research Network: Clinical Validation Centers (U01): at 1:00 pm - 2:30 pm EDT; and
3) RFA-CA-21-034 - The Early Detection Research Network: Data Management and Coordinating Center (U24): at 2:30 pm - 4:00 pm EDT.
NCI staff members involved in managing this program will provide technical assistance to potential applicants by explaining the goals and objectives of this initiative and answering questions from attendees. Potential applicants are encouraged to submit their questions or comments to [email protected] in advance of the teleconference.
Registration: Potential applicants interested in participating in the teleconference should send an email to:
to obtain registration information no later than 5:00 p.m. (EDT) July 06, 2021.
Please include "NCI Technical Assistance Webinar for EDRN FOAs” in the subject line of the email.
Participation in this teleconference, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-21-033, RFA-CA-21-034 or RFA-CA-21-035.
Sudhir Srivastava, PhD., MPH
National Cancer Institute (NCI)
Telephone: 240-276-7028
Email: [email protected]